Advertisement
Advertisement
WST
West Pharmaceutical Services, Inc.
309.97
USDSponsored
+9.79
+3.26%
May 05, 16:00 UTC -4
Closed
After-Market
309.95
-0.02
-0.01%
WST Earnings Reports
Positive Surprise Ratio
WST beat 36 of 41 last estimates.
88%
Next Report
Date of Next Report
Jul 22, 2026
Estimate for Q2 26 (Revenue/ EPS)
$847.96M
/$2.11
Implied change from Q1 26 (Revenue/ EPS)
+0.36%
/-0.94%
Implied change from Q2 25 (Revenue/ EPS)
+10.63%
/+14.67%
West Pharmaceutical Services, Inc. earnings per share and revenue
On Apr 23, 2026, WST reported earnings of 2.13 USD per share (EPS) for Q1 26, beating the estimate of 1.69 USD, resulting in a 25.78% surprise. Revenue reached 844.90 million, compared to an expected 787.77 million, with a 7.25% difference. The market reacted with a +12.86% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of 2.11 USD, with revenue projected to reach 847.96 million USD, implying an decrease of -0.94% EPS, and increase of 0.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Cardinal Health, Inc.
Report Date
Apr 30, 2026 For Q3 26
Estimate
$2.81
Actual
$3.17
Surprise
+12.58%
Align Technology Inc
Report Date
Apr 29, 2026 For Q1 26
Estimate
$2.32
Actual
$2.58
Surprise
+10.96%
Henry Schein Inc
Report Date
May 05, 2026 For Q1 26
Estimate
$1.24
Actual
$1.32
Surprise
+6.31%
Merit Medical Systems Inc
Report Date
Apr 30, 2026 For Q1 26
Estimate
$0.84
Actual
$0.94
Surprise
+10.68%
DENTSPLY SIRONA Inc.
Report Date
May 05, 2026 For Q1 26
Estimate
$0.28
Actual
$0.27
Surprise
-5.26%
CONMED Corporation
Report Date
Apr 29, 2026 For Q1 26
Estimate
$0.83
Actual
$0.89
Surprise
+6.54%
Pro-Dex Inc New
Report Date
Apr 30, 2026 For Q3 26
Estimate
$0.63
Actual
$1.20
Surprise
+89.75%
FAQ
What were West Pharmaceutical Services, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, West Pharmaceutical Services, Inc. reported EPS of $2.13, beating estimates by 25.78%, and revenue of $844.90M, 7.25% above expectations.
How did the market react to West Pharmaceutical Services, Inc.'s Q1 2026 earnings?
The stock price moved up 12.86%, changed from $274.41 before the earnings release to $309.70 the day after.
When is West Pharmaceutical Services, Inc. expected to report next?
The next earning report is scheduled for Jul 22, 2026.
What are the forecasts for West Pharmaceutical Services, Inc.'s next earnings report?
Based on 12
analysts, West Pharmaceutical Services, Inc. is expected to report EPS of $2.11 and revenue of $847.96M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement